Skip to content
← Back to this collection

PUBLICATIONS · 16760270

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2006 Jun
First author
Boccardo F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Boccardo F
      type
      Author
    2. name
      Rubagotti A
      type
      Author
    3. name
      Guglielmini P
      type
      Author
    4. name
      Fini A
      type
      Author
    5. name
      Paladini G
      type
      Author
    6. name
      Mesiti M
      type
      Author
    7. name
      Rinaldini M
      type
      Author
    8. name
      Scali S
      type
      Author
    9. name
      Porpiglia M
      type
      Author
    10. name
      Benedetto C
      type
      Author
    11. name
      Restuccia N
      type
      Author
    12. name
      Buzzi F
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Boccardo F
      type
      Author
    2. name
      Rubagotti A
      type
      Author
    3. name
      Guglielmini P
      type
      Author
    4. name
      Fini A
      type
      Author
    5. name
      Paladini G
      type
      Author
    6. name
      Mesiti M
      type
      Author
    7. name
      Rinaldini M
      type
      Author
    8. name
      Scali S
      type
      Author
    9. name
      Porpiglia M
      type
      Author
    10. name
      Benedetto C
      type
      Author
    11. name
      Restuccia N
      type
      Author
    12. name
      Buzzi F
      type
      Author
    bibliography ids
    1. nci-bib-75b2119905b56c9481d175a8
    book metadata
    content sha256
    1d7f0c219a1666afb471f68072fbcde4d4e886c2bf858567fd4a1b269cafb52c
    document type
    citation
    dois
    1. 10.1093/annonc/mdl941
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16760270
    immutable id
    pubmed:16760270@1d7f0c219a1666afb471f68072fbcde4d4e886c2bf858567fd4a1b269cafb52c
    journal
    abbreviation
    Ann Oncol
    issn electronic
    1569-8041
    issn print
    0923-7534
    issue
    Source null
    name
    Annals of oncology : official journal of the European Society for Medical Oncology
    nlm unique id
    9007735
    pages
    vii10-4
    volume
    17 Suppl 7
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16760270
      provenance
      batch id
      19fb2de9a00882c94e86
      provider
      NCBI PubMed ESummary
      record sha256
      bf2453663bd67c40a345050e1bd641f17b844a9f94cc5db6f4503bb78fbf27b5
      response sha256
      4c446464d8fd06bff771a2bb5f3529ef4abe372e3c19f6fb7223068d839a263d
      retrieved at
      2026-09-09T23:46:06.810486+00:00
      publication date
      display
      2006 Jun
      precision
      month
      year
      2006
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16760270/
      title
      Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial.

      Preserved source evidence · Not medical advice